E
Neurogene Inc. NGNE
$15.00 $1.9715.12% NASDAQ
Recommendation
Prev Close
$13.03
Volume
168,855
Avg Vol (90D)
266,940
Market Cap
$185.83M
Dividend & Yield
--
52-Week Range
$6.88 - $74.49
P/E (TTM)
--
EPS (TTM)
-$4.29
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Neurogene (NGNE, $13.03) price exceeded its 50-day Moving Average on April 29, 2025
4/30/2025 - Tickeron - Stocks
Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare ...
4/28/2025 - GuruFocus
Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare ...
4/28/2025 - GuruFocus
Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual Meeting
4/28/2025 - Business Wire
Neurogene (NGNE, $15.44) price moved above its 50-day Moving Average on April 23, 2025
4/24/2025 - Tickeron - Technical Analysis
Neurogene (NGNE, $13.83) price may drop as it broke higher Bollinger Band on Apr 22, 2025
4/23/2025 - Tickeron - Stocks
Rock Springs Capital Management LP Invests $2.18 Million in Neurogene Inc. (NASDAQ:NGNE)
4/21/2025 - Ticker Report
Neurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Buy" by Brokerages
4/21/2025 - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Shares Bought by Walleye Capital LLC
4/20/2025 - Ticker Report
Neurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Buy" by Brokerages
4/19/2025 - Ticker Report
Neurogene (NGNE, $11.49) Aroon Indicator entered a Downtrend on April 17, 2025.
4/18/2025 - Tickeron - Stocks
Neurogene (NGNE, $10.77) Aroon Indicator entered a Downtrend on April 16, 2025.
4/17/2025 - Tickeron - Stocks
BMO Capital Markets Has Lowered Expectations for Neurogene (NASDAQ:NGNE) Stock Price
4/16/2025 - MarketBeat
Neurogene (NGNE, $11.36) entered Uptrend as Momentum indicator ascends above 0 level on Apr 15, 2025
4/16/2025 - Tickeron - Stocks
Neurogene (NGNE, $11.36) Aroon Indicator entered a Downtrend on April 15, 2025.
4/16/2025 - Tickeron - Stocks
Neurogene (NGNE, $10.89) Aroon Indicator entered a Downtrend on April 14, 2025.
4/15/2025 - Tickeron - Stocks
Neurogene (NGNE, $10.89) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 14, 2025
4/15/2025 - Tickeron - Stocks
BMO Capital Adjusts Price Target for Neurogene (NGNE) Amid Recent Developments NGNE Stock News
4/14/2025 - GuruFocus
Neurogene price target lowered by $29 at BMO Capital, here's why
4/14/2025 - The Fly
Neurogene (NGNE, $11) Stochastic Oscillator left the oversold zone on April 11, 2025
4/12/2025 - Tickeron - Technical Analysis
Neurogene (NGNE, $11) Aroon Indicator entered a Downtrend on April 11, 2025.
4/12/2025 - Tickeron - Technical Analysis
Neurogene (NGNE, $8.97) Aroon Indicator entered a Downtrend on April 10, 2025.
4/11/2025 - Tickeron - Stocks
Analysts Forecast 37% Upside For The Holdings of RFLR
4/10/2025 - ETF Channel
Neurogene (NGNE, $9.03) Aroon Indicator entered a Downtrend on April 09, 2025.
4/10/2025 - Tickeron - Stocks
Neurogene (NGNE, $9.03) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$925.00K
EBITDA (TTM)
-$79.36M
EBIT (TTM)
-$82.61M
Net Income (TTM)
-$75.14M
Balance Sheet
Total Assets (Q)
$335.73M
Total Debt (Q)
$12.43M
Total Liabilities (Q)
$25.36M
Book Value Per Share (Q)
$20.89
Cash Flow
Cash from Operations (TTM)
-$70.60M
Cash from Investing (TTM)
-$125.26M
Cash from Financing (TTM)
$184.07M
Net Change in Cash (TTM)
-$11.79M
Filings
Filing Date
Monday, March 24, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
--
7-Day Total Return
24.79%
30-Day Total Return
-5.36%
60-Day Total Return
-10.93%
90-Day Total Return
-36.76%
Year to Date Total Return
-34.47%
1-Year Total Return
-56.50%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 08, 2025 - $6.88
52-week High
Nov 11, 2024 - $74.49
Valuation
Market Cap
$185.83M - Micro Cap
Enterprise Value
-$114.14M
Price/Sales (TTM)
274.32
Price/Book (Q)
0.62
Dividends and Shares
Shares Outstanding
19.47M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.neurogene.com
Phone Number
855 508 3568
Address
535 W 24th Street
New York, NY 10011
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an... more
NASDAQ 04/30/2025 4:00PM Eastern Quotes delayed